The St. Louis Metropolitan Medical Society is pleased to announce a new member benefit, the Medtech Community Investment Program, made available through a unique partnership with iSelect Fund Management, LLC. Based in St. Louis, iSelect invests in early stage technology-enabled ventures throughout the United States, particularly companies that are bringing innovation to healthcare. Its iSelect Fund allows accredited investors to assemble a diversified portfolio of the country’s most promising emerging growth companies.
Members of SLMMS will have access to preferential pricing through the iSelect Affinity Program and will be able to invest directly in companies that iSelect sources, including medical technology and other industry-specific early stage companies. SLMMS physicians will also have the opportunity to participate in iSelect Fund Selection Committees utilizing their unique medical experience, and those who participate can earn additional carried interest in iSelect portfolio companies.
iSelect recognizes that doctors provide keen insight into healthcare needs, so its Affinity Program works directly with partners to integrate their industry and market insight into the iSelect investment process, communicating with key industry leaders to accelerate the most promising opportunities. SLMMS members aware of potential investment opportunities are also encouraged to refer them to iSelect for evaluation and review, and iSelect is hopeful that SLMMS physicians will, via the portfolio companies, discover interesting technologies, products and services to put to use in their own practices.
Please note that SLMMS will not be vetting these potential investment opportunities, but may provide necessary medical and professional expertise to iSelect in their evaluation process.
iSelect has also pledged to work with SLMMS to develop educational programs for members to introduce new technologies emerging from local entrepreneurs, as well as other relevant topics applicable to medical practices and early stage venture investments. To learn more about the next presentation in the iSelect Speaker series, an evening with Neuros Medical, Inc., on Wednesday, June 8 at the Missouri Athletic Club West, 1777 Des Peres Road, click HERE. All SLMMS members are invited to this informational event.
A new kind of venture capital fund (VC), iSelect helps its portfolio companies accelerate growth and value accretion by providing an array of post-investment services, including corporate development support, customer introductions, and talent recruiting. Unlike a traditional VC, however, iSelect can offer access to its portfolio of companies to a wide range of accredited investors.
SLMMS has pursued this opportunity in response to the growth in the medtech start-up community in St. Louis. Simultaneous with launching this benefit, the SLMMS Council has approved the formation of a SLMMS Innovation Committee, to serve as the key point of contact for the iSelect investment program.
To learn more about iSelect Fund and the benefit available SLMMS members, contact the SLMMS office or Dan Schaub, iSelect chief operating officer, at 314-288-7855 or email@example.com
To read more about the SLMMS iSelect Affinity Program, click HERE
To review the iSelect Portfolio of Companies (as of 2nd Quarter 2016), click HERE